GE auisys cs2, Руководство пользователя

Страница: 29 / 268

device containing phthalates is used for treatment of
children or treatment of pregnant or nursing women:
• Exchange transfusion in neonates, total parenteral
nutrition in neonates, multiple procedures in sick
neonates, haemodialysis in peripuberal males, male
fetus and male infant of pregnant women, and
lactating women; and massive blood infusion into
trauma patients. Although these procedures have the
potential for increased risk of exposure, conclusive
evidence of human health risks has not been
established. As a precautionary measure, to reduce
the potential for unnecessary exposures to
phthalates, the product must be used in accordance
with the instructions for use, and practitioners should
refrain from using this product beyond the period of
time the product is medically necessary or needed.
Follow hospital procedures for the prevention and
treatment of malignant hyperthermia for patients sensitive
to inhalation anesthetic agents.
Risk of fire. Limit the use of supplemental oxygen
concentrations to less than 30 percent when using a heat
source or device that may lead to combustion. Consult
facility risk management procedures to minimize the risk
of fire if an oxygen concentration of more than 30 percent
is required for any reason.
This system is not intended for use where the
surrounding oxygen concentration is in excess of 25
percent. Increased oxygen concentrations can result in
an increased risk of fire.
See " Device standards IEC 60601-1 2005 " and " Integral system
components " for information regarding monitoring built into this
device.
Inspecting the system
Before using the system, make sure that:
• The equipment is not damaged.
• Components are correctly attached.
• The breathing circuit is correctly connected and not damaged.
• The breathing system is correctly assembled and contains
sufficient absorbent. Refer to the “Cleaning and Sterilization”
manual for breathing system assembly instructions.
• The Aladin cassette is locked in position and contains sufficient
agent.
•
•
•
1 Introduction
2067226-001
1-17